Here’s how the companies’ results compare with the fourth quarter of 2021:
Total revenue: $4.7 billion (+10.3 percent)
Total orthopedic and spine sales: $2.1 billion (+12.5 percent)
Hips: $352 million (+3.2 percent)
Knees: $523 million (+14.2 percent)
Spine: $300 million (-1.8 percent)
Total revenue: $2 billion (-2.3 percent)
Hips: $480.7 million (-4.6 percent)
Knees: $720.1 million (-0.8 percent)
Spine and dental: $260 million (-4.1 percent)
Total revenue: $24.8 billion (+10.4 percent)
Orthopedics: $2.2 billion (-1.6 percent)
Hips: $380 million (+2.1 percent)
Knees: $342 million (-0.9 percent)
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.